ALPUVI / TIRZEPATIDE · LABEL VISUALIZATIONRESEARCH PEPTIDE / LY3298176
Tirzepatide
Dual receptor agonist
A synthetic peptide studied for its activity at the GIP and GLP-1 receptor pathways.
CAS number2023788-19-2
Supply formatVials · specification on inquiry
Research eligibility is reviewed before supply. This is an inquiry, not an order.
Know your compound.
Reference information describes the named peptide. Batch-specific composition and analytical results are published in the Results tab.
Reference chemical data — Lilly, section 11 Receptor identity reference- Molecular formula
- C₂₂₅H₃₄₈N₄₈O₆₈
- Reference molar mass
- 4,813.53 g/mol
- Receptor pathways
- GIP / GLP-1
- Development identifier
- LY3298176
- Batch formulation / salt form
- See batch results
Reference values do not certify an Alpuvi batch. Salt form, excipients, vial content and analytical purity must be confirmed from the supplied documentation.
For laboratory research only. Not for human or veterinary use. Alpuvi does not provide instructions for personal administration.